SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

Exhibit No.   Description
2.1   Asset Purchase Agreement, dated as of February 18, 2019, by and among Pernix Therapeutics Holdings, Inc., the other Sellers party thereto, and Phoenix Top Holdings LLC.*
10.1   Letter Agreement, dated February 13, 2019, by and between Pernix Therapeutics LLC and John Sedor
10.2   Letter Agreement, dated February 13, 2019, by and between Pernix Therapeutics LLC and Kenneth R. Piña
10.3   Letter Agreement, dated February 13, 2019, by and between Pernix Therapeutics LLC and Glenn Whaley

99.1 

 

Press release dated February 19, 2019. 

99.2   Disclosure Information provided in connection with discussions with the Purchaser and certain noteholders. 

 

*       Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K and the Company agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted schedule and/or exhibit upon request.